- CVS Caremark to stop selling tobacco in all store locations
- CVS' Merlo: Health reform to benefit business in 2014
- CVS Caremark research identifies optimal elements of effective VBID plans
- ROUNDTABLE: Pharmacy’s future in sync with technology
- CVS Caremark's 'ability' and 'agility' a key focus of 2013 Analyst Day
WOONSOCKET, R.I. — CVS Caremark announced on Thursday that it has been awarded pharmacy benefit management and drug therapy management accreditation from URAC, a healthcare accrediting organization that establishes quality standards for the healthcare industry. CVS Caremark previously had received accreditation for PBM and DTM from URAC in 2007.
"CVS Caremark is pleased to receive these accreditations," stated Per Lofberg, head of CVS Caremark's PBM business. "This provides further validation of the company's ongoing focus and commitment to patient care, outstanding customer service and overall quality."
URAC offers the only third-party, voluntary accreditation program of this scope for the PBM and prescription services industry. All standards were developed by URAC's Pharmacy Advisory Committee, which includes stakeholders, employers, consumers, pharmacy consultants, health plans, retail pharmacy, PBM organizations, pharmacy professional organizations, labor and large public purchasing groups.
"By applying for and receiving URAC accreditation, CVS Caremark has demonstrated a commitment to quality health care," added Alan Spielman, URAC president and CEO. "Quality health care is crucial to our nation's welfare, and it is important to have organizations that are willing to measure themselves against national standards and undergo rigorous evaluation by an independent accrediting body."